Venmax Drugs and Pharmaceuticals Limited

Equities

531015

INE154G01022

Venmax Drugs and Pharmaceuticals Limited Approves Resignation of Sadan Grover from the Post of Company Secretary & Compliance Officer

April 20, 2024 at 01:25 pm

Venmax Drugs and Pharmaceuticals Limited at its board meeting held on April 20, 2024 has considered and approved the Resignation of Mr. Sadan Grover from the post of Company Secretary & Compliance Officer. The
Board accepted his resignation and relieved him from all responsibilities with effect from April, 20, 2024.

Latest news about Venmax Drugs and Pharmaceuticals Limited

Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	05-14	CI
Venmax Drugs and Pharmaceuticals Limited Approves Resignation of Sadan Grover from the Post of Company Secretary & Compliance Officer	04-20	CI
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	01-30	CI
Venmax Drugs and Pharmaceuticals Limited Announces Change in Management	01-16	CI
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	11/08/23	CI
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	15/05/23	CI
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	30/01/23	CI
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	04/11/22	CI
Venmax Drugs and Pharmaceuticals Limited Auditor Raises 'Going Concern' Doubt	15/09/22	CI
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	30/07/22	CI
Venmax Drugs and Pharmaceuticals Limited Approves Shifting of Registered Office	30/07/22	CI
Venmax Drugs and Pharmaceuticals Limited Proposes the Resignation of Shri Ramakrishnaiah Appanaboyana as Independent Director	23/07/22	CI
Venmax Drugs and Pharmaceuticals Limited Announces Executive Changes	13/02/21	CI
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020	13/02/21	CI
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020	11/11/20	CI
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2020	07/09/20	CI
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2020	29/06/20	CI
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Second Quarter Ended September 30, 2019	14/11/19	CI
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2019	13/08/19	CI
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2019	18/05/19	CI
Venmax Drugs and Pharmaceuticals Limited Appoints Rajkumar Rai as Compliance Officer	15/05/19	CI
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Third Quarter Ended December 31, 2018	14/02/19	CI
Venmax Drugs and Pharmaceuticals Ltd Reports Earnings Results for the Second Quarter Ended September 30, 2018	15/11/18	CI
Venmax Drugs and Pharmaceuticals Limited Announces Unaudited Earnings Results for the First Quarter Ended June 30, 2018	14/08/18	CI
Venmax Drugs & Pharmaceuticals Ltd. Reports Audited Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2018	28/05/18	CI

Chart Venmax Drugs and Pharmaceuticals Limited

Duration

Period

Chart Venmax Drugs and Pharmaceuticals Limited

More charts

Company Profile

Sector

Calendar

11/08/2024 - Q1 2025 Earnings Release (Projected)

More about the company